Metastatic Colorectal Cancer - SMT112-3005 / HARMONi-GI3

A Randomized, Active-Controlled, Double-blind, Multicenter, Phase 3 Clinical Study of Ivonescimab in Combination with mFOLFOX6 (Oxaliplatin, Leucovorin and 5-Fluorouracil) versus Bevacizumab in Combination with FOLFOX for the First-line Treatment of Metastatic Colorectal Cancer(HARMONi-GI3)

ClinicalTrials.gov Link: https://clinicaltrials.gov/study/NCT07228832?viewType=Card&id=smt112-3005&rank=1

Locations: Hartford Hospital, Hartford HealthCare Cancer Institute at The Hospital of Central Connecticut, Hartford HealthCare Cancer Institute - Avon, Hartford HealthCare Medical Group - Manchester, MidState Medical Center

Contact: Holly Maheu: holly.maheu@hhchealth.org